Gsk (GSK) Net Income - Minority (2009 - 2017)
Gsk (GSK) posted quarterly Net Income - Minority of -$647.9 million for Q4 2017, up 30.79% year-over-year from -$495.4 million in Q4 2016, and up 30.79% quarter-over-quarter from -$936.1 million in Q4 2016.
Gsk (GSK) Net Income - Minority (2009 - 2017) Analysis & Trends
Gsk's Net Income - Minority history runs 9 years deep, the most recent figure standing at -$647.9 million for Q4 2017.
- In Q4 2017, Net Income - Minority rose 30.79% year-over-year to -$647.9 million; the TTM figure through Dec 2017 stood at -$647.9 million (up 30.79% YoY), while the FY2017 annual figure was -$628.7 million, up 38.46% from the prior year.
- Net Income - Minority for Q4 2017 stood at -$647.9 million, up from -$936.1 million in the prior quarter.
- The five-year high for Net Income - Minority was $63.7 million in Q4 2015, with the low at -$936.1 million in Q4 2016.
- The 5-year median for Net Income - Minority is -$254.2 million (2013), against an average of -$383.7 million.
- The sharpest annual moves came in 2015 and 2016: Net Income - Minority jumped 144.2% in 2015, then tumbled 1568.82% in 2016.
- Gsk's Net Income - Minority stood at -$254.2 million in 2013, then jumped by 43.28% to -$144.2 million in 2014, then surged by 144.2% to $63.7 million in 2015, then slumped by 1568.82% to -$936.1 million in 2016, then jumped by 30.79% to -$647.9 million in 2017.
- Business Quant data shows GSK's Net Income - Minority at -$647.9 million in Q4 2017, -$936.1 million in Q4 2016, and $63.7 million in Q4 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income - Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | - |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | - |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | - |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | - |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -647.90 Mn |
| Dec 31, 2016 | -936.15 Mn |
| Dec 31, 2015 | 63.73 Mn |
| Dec 31, 2014 | -144.18 Mn |
| Dec 31, 2013 | -254.19 Mn |
| Dec 31, 2012 | -239.27 Mn |
| Dec 31, 2011 | -6.29 Mn |
| Dec 31, 2010 | -18.96 Mn |
| Dec 31, 2009 | -6.53 Mn |
| Mar 31, 2009 | -37.36 Mn |